Charles Ssemuyiga

Mr. Charles Ssemuyiga

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2025 in Frontiers in Artificial Intelligence
Verified
Journal Article
Open access
PDF file
OAOlaitan I. Awe
Olaitan I. Awe
HOHesborn Obura
Hesborn Obura
CSCharles Ssemuyiga
Charles Ssemuyiga
EMEvans Mudibo
Evans Mudibo
MMMike J. Mwanga
Mike J. Mwanga
Introduction: Rapid and scalable classification of SARS-CoV-2 genomes from spike-gene sequences can support real-time genomic surveillance in contexts where whole-genome data or high-end computing resources are limited.Methods: We curated approximately 35,800 quality-filtered spike sequences spanning multiple clades and lineages and trained a hybrid CNN–BiLSTM model with standard regularization and class-imbalance handling. Model performance was benchmarked against Nextclade assignments and compared with classical machine-learning baselines.Results: Across 10 experimental runs, the model achieved a mean training accuracy of 99.74% ± 0.11, a validation accuracy of 99.00% ± 0.00, and a test accuracy of 99.91% ± 0.03. In benchmarking against the molecular epidemiology tool Nextclade, our model demonstrated superior performance, correctly identifying 100% of Omicron sequences, compared to 34.95% achieved by Nextclade. Saliency and feature attribution analyses highlighted recurrent spike substitutions consistent with known variant-defining mutations, as well as additional uncharacterized motifs with potential biological relevance.Discussion: These findings demonstrate that spike-only deep models can provide rapid and accurate clade or variant classification, while also yielding interpretable feature importance. Such models complement phylogenetic approaches in settings with constrained resources and enable efficient triage of samples for confirmatory whole-genome analysis, supporting more timely genomic surveillance.

1 January 2024 in Biomedical Engineering and Computational Biology
Verified
Journal Article
Open access
CSCharles Ssemuyiga
Charles Ssemuyiga
MEMulumba Pius Edgar
Mulumba Pius Edgar
Introduction: The rate of acute hepatitis C increased by 7% between 2020 and 2021, after the number of cases doubled between 2014 and 2020. With the current adoption of pan-genotypic HCV therapy, there is a need for improved availability and accessibility of this therapy. However, double and triple DAA-resistant variants have been identified in genotypes 1 and 5 with resistance-associated amino acid substitutions (RAASs) in NS3/4A, NS5A, and NS5B. The role of this research was to screen for novel potential NS5B inhibitors from the cannabis compound database (CBD) using Deep Learning. Methods: Virtual screening of the CBD compounds was performed using a trained Graph Neural Network (GNN) deep learning model. Re-docking and conventional docking were used to validate the results for these ligands since some had rotatable bonds >10. About 31 of the top 67 hits from virtual screening and docking were selected after ADMET screening. To verify their candidacy, 6 random hits were taken for FEP/MD and Molecular Simulation Dynamics to confirm their candidacy. Results: The top 200 compounds from the deep learning virtual screening were selected, and the virtual screening results were validated by re-docking and conventional docking. The ADMET profiles were optimal for 31 hits. Simulated complexes indicate that these hits are likely inhibitors with suitable binding affinities and FEP energies. Phytil Diphosphate and glucaric acid were suggested as possible ligands against NS5B.

30 August 2023 in Research Square
Verified
Preprint
Open access
PDF file
CSCharles Ssemuyiga
Charles Ssemuyiga
PSPaul Ssemanda
Paul Ssemanda
EPEdgar Mulumba Pius
Edgar Mulumba Pius
AKAnthony Ndugwa Kasoma
Anthony Ndugwa Kasoma
Saidi NtambiSaidi Ntambi
Saidi Ntambi
Cases of the monkeypox virus have been recorded in non-endemic nations and have continued to be reported in several endemic nations since early May 2022 [1]. In this study, we modeled MPXV Thymidylate Kinase (TMPK) and scaffolding protein (D13), and these models and their templates were taken for small molecule screening against 602,413 small molecules using pharmacophore modeling and molecular docking methods. ADMET properties were also computed followed by Molecular simulation dynamics studies. All presented hits had superior molecular docking scores to used reference standards of Cidofovir and Rifampicin. TMPK compounds displayed better ADMET profiles than D13 compounds, hence the latter may necessitate optimization. Following molecular dynamics simulation, calculations of the RMSDs, RMSFs, Hydrogen Bonds, SASA, Radius of Gyration, MM-GBSA energy, PCA, and DCC revealed that all generated complexes were stable, with the ligands NPC275538, NPC244454, 135566871, and CHEBI compounds outperforming other Hits. These compounds still presented higher docking scores against cidofovir-resistant TMPK and Rifampicin-resistant D13 proteins. Compounds 447970, 446595, and 54723327 were most selective against human TMPK. The conserved interaction patterns of these compounds among Vaccinia and Monkeypox virus proteins with the fact that studied proteins are highly conserved across Orthopoxviruses (OPV) is appealing to the fact these hits should be studied across OPV. Therefore, these compounds should be subjected to laboratory testing to prove their antipox capability. Since there are currently no approved MPXV antivirals, this discovery significantly aids in developing new drugs for treating monkeypox.

12 May 2026 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
CSCharles Ssemuyiga
Charles Ssemuyiga
ESElminah Saru
Elminah Saru
YAYusuf Abbas Aleshinloye
Yusuf Abbas Aleshinloye
Introduction: Typhoid fever remains a major Global public health concern, with treatment outcomes strongly influenced by antimicrobial resistance (AMR) and inter-patient variability. Determining the most appropriate antibiotic for an individual patient remains clinically challenging. Machine learning–based clinical decision support systems (CDSS) offer a promising avenue for improving diagnostic precision and guiding antibiotic selection using routinely collected clinical data. Methods: We developed a machine learning-based decision-support framework using XGBoost models to predict (i) treatment outcome (binary), (ii) suspected typhoid classification, and (iii) a resistance-proxy score from clinical and engineered features. Model performance was evaluated using AUROC for classification tasks and R 2 for regression, alongside probability calibration analysis using the Brier score. SHAP was used to interpret feature importance, generate patient-level explanations, and identify latent patient subgroups. A counterfactual drug-simulation experiment was further implemented to compare clinician-prescribed antibiotics with model-recommended alternatives. Results: The treatment outcome classifier demonstrated strong generalization performance, achieving a test AUROC of 0.962 ± 0.010 and an overall accuracy of 90%. The suspected typhoid classifier achieved an AUROC of 0.902 ± 0.005 with an overall classification accuracy of 82%. The resistance-proxy regression model showed moderate predictive capacity (R 2 = 0.588 ± 0.011). SHAP analysis identified platelet count, age, hemoglobin, calcium, potassium, and severity score as dominant predictors across models and revealed biologically coherent patient subgroups through attribution-based clustering. Counterfactual drug simulations showed that the model’s top recommendation matched the clinician-prescribed drug in 37.1% of cases and appeared as the second-rankedt option in 28.2% of cases. Treatment success was highest when prescriptions aligned with the model’s primary recommendation (72.7%) and lowest when no alignment was observed (32.6%). Conclusion: This study demonstrates the feasibility of using machine learning to simulate antibiotic selection in typhoid treatment using patient-level clinical profiles. It presents a machine learning-based decision-support framework for antibiotic optimization under uncertainty, with explicit relevance to antimicrobial resistance management in resource-limited settings. To our knowledge, this is among the first studies to integrate explainable machine learning with counterfactual drug simulation for antibiotic optimization in typhoid fever.

6 September 2023 in Research Square
Verified
Preprint
Open access
PDF file
CSCharles Ssemuyiga
Charles Ssemuyiga
RSV remains a burden on healthcare systems and society despite medical advancements. For over 60 years, developing a vaccine for RSV has been a top priority, but efforts have been ineffective. The physical interactions between Nucleolin (NCL) RBD1,2 and RSV-F protein during virus entry were identified by peptide arrays as two antiparallel strands of β-sheet in RBD1. I screened for novel NCL-targeting ligands to inhibit this interaction. In a nutshell, small molecule inhibitors and nucleic acid aptamers were specifically docked to NCL RBD1, 2. A total of 528 aptamers were docked to NCL RBD1,2 on the HDOCK website; the top 180 aptamers with docking scores equal to or better than -200 were then re-docked at the HADDOCK website, and the top 58 aptamers were chosen. Additionally, 976,450 small molecules were docked using Schrodinger Virtual Screening Workflow, and the top 50 ligands underwent post-docking validation using Prime MM_GBSA. The 16 best ligands were chosen from the top 30 using binding affinity from Molegro Virtual Docker. For molecular simulation dynamics studies, four protein-ligand complexes and six protein-aptamer complexes were randomly chosen and the results were analyzed. The results show that the selected NCL ligands are potential NCL binders and can inhibit NCL-RSV-F interactions. Results suggest that aptamers are better binders than small molecules. BDBM50308336, 1exd, and 5uza formed the most stable complexes. With many benefits as host-directed therapeutics, these ligands need in-vitro testing for potential inhibition of RSV entry besides some probable drawbacks.

7 December 2025 in medRxiv
Verified
Preprint
Open access
PDF file
CSCharles Ssemuyiga
Charles Ssemuyiga
ESElminah Saru
Elminah Saru
YAYusuf Abbas Aleshinloye
Yusuf Abbas Aleshinloye
Introduction: Typhoid fever remains a major Global public health concern, with treatment outcomes dependent on antimicrobial resistance (AMR) and patient variability. Clinically determining the best medication for a certain patient can be difficult. Machine learning–based clinical decision support systems (CDSS) offer a promising avenue for improving diagnostic accuracy and guiding antibiotic selection using routinely collected clinical data Methods: We developed a multi-task predictive framework using XGBoost models to predict (i) treatment outcome/success (binary), (ii) treatment duration (days), (iii) a resistance-proxy score, and (iv) suspected typhoid using clinical data; we assessed discrimination (AUC), calibration (Brier), and R² where appropriate, and used SHAP for explainability to interpret feature importance, derive patient clusters, and generate individualized model explanations. We further implemented a counterfactual drug-simulation experiment to compare actual prescribed antibiotics with predicted best options for each patient Results: The treatment outcome and suspected typhoid classification models achieved an AUROC of 0.9998 ± 0.0001 and 0.9834 ± 0.0007 respectively, accurately distinguishing between successful and failed therapies and typhoid and non-typhoid cases respectively. The treatment-duration and resistance-proxy regression models demonstrated strong explanatory capacity, accounting for 80% (R² = 0.8027 ± 0.0054) and 90% (R² = 0.9014 ± 0.0036) of the variance in therapy length and inferred resistance likelihood, respectively. SHAP analysis consistently highlighted the severity group, biochemical markers as dominant predictors across models and revealed biologically coherent patient subgroups. Counterfactual drug simulations suggested that alternative antibiotics could yield higher predicted success probabilities for a subset of patients, indicating the potential value of model-informed treatment ranking Conclusion: This study demonstrates the feasibility of machine learning for simulating drug choice in typhoid treatment using patient clinical profiles.